Molecular and genetic mechanisms of prostate cancer

Radiation Research

Volumn 155, Issue 1, 2001, Pages 128-132

  Rhim, Johng S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL LINE; CELL TRANSFORMATION; GENETICS; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; REVIEW; VIROLOGY;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0035219014     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0128:MAGMOP]2.0.CO;2     Document Type: Article

References (30)

1. S. L. Parker, T. Tong, S. Bolden and P. A. Wingo, Cancer statistics. CA Cancer J. Clin. 47, 5-27 (1997).
2. P. Davies, C. L. Eaton, T. D. France and E. A. Phillips, Growth factor receptors and oncogene expression in prostate cells. Am. J. Clin. Oncol. 11 (Suppl. 2), s1-s7 (1988).
3. H. Suniya, M. Masai, S. Akimoto, R. Yatani and J. Shimazaki, Histochemical examination of ras p21 protein and R1881-binding protein in human prostatic cancers. Eur. J. Cancer 26, 786-789 (1990).
4. K. Anwar, K. Nakakuki, T. Shiraishi, H. Naiki, R. Yatani and M. Inuzuka, Presence of ras on oncogene mutations and human papilloma virus DNA in human prostate carcinomas. Cancer Res. 52, 5991-5996 (1992).
5. B. S. Carter, J. I. Epstein and W. B. Isaacs, Ras gene mutations in human prostate cancer. Cancer Res. 50, 6830-6832 (1991).
6. P. H. Gremerlock, U. R. Poonamallee, F. J. Meyers and R. W. White, Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res. 51, 1632-1637 (1991).
7. P. A. McNicol and J. G. Dodd, High prevalence of human papilloma virus in prostate tissues. J. Urol. 145, 850-853 (1991).
8. J. Serth, F. Panitz, U. Paeslack, M. A. Kuczyle and U. Jonas, Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res. 59, 823-825 (1999).
9. J. S. Rhim, M. M. Webber, D. Bellow, M. S. Lee, P. Arnstein, L. S. Chen and G. Jay, Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc. Natl. Acad. Sci. USA 91, 11874-11878 (1994).
10. W. B. Isaacs, G. S. Bova, R. A. Morton, M. J. G. Bussemakers, J. D. Brooks and C. M. Ewing, Molecular genetics and chromosomal alterations in prostate cancer. Cancer Res. 77 (Suppl.), 2004-2012 (1995).
11. J. S. Rhim, S. Jin, M. Jung, P. Thraves, M. R. Kuettel, M: M. Webber and B. Hukku, Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. Cancer Res. 57, 576-580 (1997).
12. A. Houweling, P. J. van den Elsen and A. J. van der Eb, Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology 105, 537-550 (1980).
13. H. L. Land, F. Parada and R. A. Weinberg, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
14. L. R. Garrett, N. Perez P. P. Smith and J. K. McDougall, Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 14, 329-332 (1993).
15. P. N. Magee, The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv. 8, 207-239 (1989).
16. G. M. Cooper, Cellular transforming genes. Science 217, 801-806 (1982).
17. N. Konishi, T. Enomoto, G. Buzard, M. Ohshima, J. M. Ward and J. M. Rice, K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69, 2293-2299 (1992).
18. A. J. Levine, J. Momand and C. A. Finlay, The p53 tumor suppressor gene. Nature 351, 453-456 (1991).
19. R. A. Weinberg, Tumor suppressor genes. Science 254, 1138-1146 (1991).
20. W. B. Isaac, B. S. Carter and C. M. Ewing, Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 51, 4716-4720 (1991).
21. B. S. Carter, C. M. Ewing, W. S. Ward, B. F. Treiger, T. W. Aalders, J. A. Schalken, J. I. Epstein and W. B. Isaacs, Allelic loss of chromosomes 16q and 1Oq in human prostate cancer. Proc. Natl. Acad. Sci. USA 87, 8751-8755 (1990).
22. J. D. Brooks, G. S. Bova, C. M. Ewing, S. Piantadosi, B. S. Carter, J. C. Robinson, J. I. Epstein and W. B. Isaacs, An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res. 56, 3814-3822 (1996).
23. F. Mitelman, Catalog of Chromosome Aberrations in Cancer, 4th ed. Wiley-Liss, New York, 1991.
24. A. R. Brothman, D. M. Reehl, A. M. Patel and J. E. McNeal, Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res. 50, 3795-3803 (1990).
25. N. B. Atkin and M. C. Baker, Chromosome 7q deletions: Observations on 13 malignant tumors. Cancer Genet. Cytogenet. 67, 123-125 (1993).
26. S. Arps, A. Rodewald, B. Schmalenberger, P. Carl, M. Bressel and H. Kastendieck, Cytogenetic survey of 32 cancers of the prostate. Cancer Genet. Cytogenet. 66, 93-99 (1993).
27. T. M. Trybur, A. C. Burgess, K. J. Wojno, T. W. Glover and J. A. Macoska, Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res. 56, 2263-2267 (1996).
28. C. D. Vocke, R. O. Pozzatti, D. G. Bostwick, C. D. Florence, S. B. Jennings, S. E. Strup, P. H. Duray, L. A. Liotta, M. R. Emmert-Buck and W. M. Linehan, Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosomal 8p12-21. Cancer Res. 56, 2411-2416 (1996).
29. M. L. Cher, G. S. Bova, D. H. Moore, E. J. Small, P. R. Carroll, S. S. Pin, J. I. Epstein, W. B. Isaacs and R. H. Jensen, Genetic alterations in untreated metastased and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56, 3091-3102 (1996).
30. R. K. Bright, C. D. Wocke, M. R. Emmert-Buck, P. H. Duray, D. Solomon, P. Fetsch, J. S. Rhim, W. M. Linehan and S. L. Topalian, Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res. 57, 995-1002 (1997).